Adveritas Secures $8.5 million to Drive U.S. Growth and Product Expansion

Highlights:

• Adveritas Limited (ASX: AV1) raised approximately AU$8.5 million through an oversubscribed institutional placement to support its U.S. expansion and product development.
• The new shares were issued at AU$0.10 each, reflecting a 67% premium to its May 2024 raise and a 4.8% discount to the 17 June 2025 closing price.
• Funds will strengthen the company’s cash position, aiding its push into e-commerce, enhancing cross-platform integrations, and supporting its path to operating profitability.

Capital Raise Boosts Strategic Plans

Adveritas Limited (ASX: AV1), a digital ad fraud prevention company, has successfully raised approximately AU$8.5 million through an oversubscribed institutional placement. At the time of writing, this capital injection was secured by issuing 85 million new shares at AU$0.10 per share, representing a 4.8% discount to its last closing price of AU$0.105 on 17 June 2025. Notably, the placement price also reflects a 67% premium to its May 2024 raise at AU$0.06. The new funding will be instrumental in advancing Adveritas' expansion strategy, particularly its entry into the U.S. market and growing presence in the e-commerce sector. The company also plans to accelerate product development and boost integration with affiliate platforms, supporting its mission to strengthen cross-selling opportunities and scale globally.

Strong Institutional Support

The placement received robust interest from both existing and new institutional investors, underscoring market confidence in Adveritas' growth potential. Settlement is expected on 25 June 2025, with shares slated for quotation on the ASX the following day under Listing Rule 7.1.

CEO Comments on Financial Position

Adveritas CEO Mathew Ratty expressed appreciation for shareholder support, noting the raise significantly improves the company’s cash reserves. “This capital raise reinforces our financial footing and positions us to target sustained operating profitability,” Ratty said. With a growing global focus on digital ad verification and fraud detection, Adveritas is expected to leverage its strengthened financial position to deepen its market penetration and drive long-term shareholder value.

Disclaimer for Kapitales Research

The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com